Clene Inc Stock, NASDAQ:CLNN
6550 South Millrock Drive, Suite G50, Salt Lake City, Utah 84121
Virgin Islands, British
Number of Employees:
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.